Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines

Toxicology and Applied Pharmacology

Volumn 220, Issue 2, 2007, Pages 197-210

  Chaudhary, Amit ^a   Pechan, Tibor ^b   Willett, Kristine L ^a  

^a Environmental Toxicology Research Program   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

2 D gel electrophoresis; BaP; Peroxiredoxin; Prostate cancer; Quercetin

Indexed keywords

BENZO[A]PYRENE; DIMETHYL SULFOXIDE; HYDROGEN PEROXIDE; PEROXIREDOXIN; PEROXIREDOXIN I; PEROXIREDOXIN II; QUERCETIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

BENZO(A)PYRENE; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; HUMANS; INDICATORS AND REAGENTS; MALE; OXIDATIVE STRESS; PEROXIDASES; PROSTATE; PROSTATIC NEOPLASMS; QUERCETIN; REACTIVE OXYGEN SPECIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34047165187     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.12.030     Document Type: Article

References (55)

1. Adegbola O., and Pasternack G.R. Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J. Biol. Chem. 280 (2005) 15497-15502
2. Alaiya A., Al-Mohanna M., and Linder S. Clinical cancer proteomics: promises and pitfalls. J. Proteome Res. 4 (2005) 1213-1222
3. Alia M., Mateos R., Ramos S., Lecumberri E., Bravo L., and Goya L. Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). Eur. J. Nutr. 45 (2006) 19-28
4. Anne S.T., Edward S.K., and Waun K.H. Chemoprevention of cancer. CA Cancer J. Clin. 54 (2004) 150-180
5. Brusselmans K., Verhoeven G., and Swinnen J.V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J. Biol. Chem. 280 7 (2004) 5636-5645
6. bu-Hamad S., Sivan S., and Shoshan-Barmatz V. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5787-5792
7. Burdick A.D., Davis J.W., Liu K.J., Hudson L.G., Shi H., Monske M.L., and Burchiel S.W. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res. 63 (2003) 7825-7833
8. Burdon R.H., Gill V., and Rice-Evans C. Cell proliferation and oxidative stress. Free Radical Res. Commun. 7 (1989) 149-159
9. Burdon R.H., Gill V., and Rice-Evans C. Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun. 11 (1990) 65-76
10. Chae H.Z., Kim H.J., Kang S.W., and Rhee S.G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45 (1999) 101-112
11. Chaudhary A., and Willett K.L. Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort. Toxicology 217 (2006) 194-205
12. Chopra D.P., and Wilkoff L.J. Induction of hyperplasia and anaplasia by carcinogens in organ cultures of mouse prostate. In Vitro 13 (1977) 260-267
13. Chopra D.P., and Wilkoff L.J. Activity of retinoids against benzo(a)pyrene-induced hyperplasia in mouse prostate organ cultures. Eur. J. Cancer 15 (1979) 1417-1423
14. Chung Y.M., Yoo Y.D., Park J.K., Kim Y.T., and Kim H.J. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res. 21 (2001) 1129-1133
15. Conrads T.P., Hood B.L., Petricoin III E.F., Liotta L.A., and Veenstra T.D. Cancer proteomics: many technologies, one goal. Expert Rev. Proteomics 2 (2005) 693-703
16. Elbekai R.H., Korashy H.M., Wills K., Gharavi N., and El-Kadi A.O. Benzo[a]pyrene, 3-methylcholanthrene and beta-naphthoflavone induce oxidative stress in hepatoma hepa 1c1c7 Cells by an AHR-dependent pathway. Free Radical Res. 38 (2004) 1191-1200
17. Fu Z., Kitagawa Y., Shen R., Shah R., Mehra R., Rhodes D., Keller P.J., Mizokami A., Dunn R., Chinnaiyan A.M., Yao Z., and Keller E.T. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66 (2006) 248-256
18. Gohara R., Imai N., Rikimaru T., Yamada A., Hida N., Ichiki M., Kawamoto M., Matsunaga K., Ashihara J., Yano S., Tamura M., Ohkouchi S., Yamana H., Oizumi K., and Itoh K. Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer. J. Immunother. 25 (2002) 439-444
19. Hess A., Wijayanti N., Neuschafer-Rube A.P., Katz N., Kietzmann T., and Immenschuh S. Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 278 (2003) 45419-45434
20. Immenschuh S., and Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal. 7 (2005) 768-777
21. Jemal A., Tiwari R.C., Taylor Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., and Thun M.J. Cancer Statistics, 2004. CA Cancer J. Clin. 54 (2004) 8-29
22. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer 37 (2000) 223-233
23. Kang S.W., Rhee S.G., Chang T.S., Jeong W., and Choi M.H. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11 (2005) 571-578
24. Keller E.T., Fu Z., and Brennan M. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J. Cell. Biochem. 94 (2005) 273-278
25. Kerzee J.K., and Ramos K.S. Activation of c-Ha-ras by benzo(a)pyrene in vascular smooth muscle cells involves redox stress and aryl hydrocarbon receptor. Mol. Pharmacol. 58 (2000) 152-158
26. Kim H., Lee T.H., Park E.S., Suh J.M., Park S.J., Chung H.K., Kwon O.Y., Kim Y.K., Ro H.K., and Shong M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J. Biol. Chem. 275 (2000) 18266-18270
27. Kinnula V.L., Lehtonen S., Sormunen R., Kaarteenaho-Wiik R., Kang S.W., Rhee S.G., and Soini Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol. 196 (2002) 316-323
28. Knowles L.M., Zigrossi D.A., Tauber R.A., Hightower C., and Milner J.A. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr. Cancer 38 (2000) 116-122
29. Kooiman G.G., Martin F.L., Williams J.A., Grover P.L., Phillips D.H., and Muir G.H. The influence of dietary and environmental factors on prostate cancer risk. Prostate Cancer Prostatic Dis. 3 (2000) 256-258
30. Lawen A., Ly J.D., Lane D.J., Zarschler K., Messina A., De P., and V. Voltage-dependent anion-selective channel 1 (VDAC1)-a mitochondrial protein, rediscovered as a novel enzyme in the plasma membrane. Int. J. Biochem. Cell Biol. 37 (2005) 277-282
31. Lee Y.J., Mazzatti D.J., Yun Z., and Keng P.C. Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin. Cell Biol. Int. 29 (2005) 877-883
32. Lehtonen S.T., Svensk A.M., Soini Y., Paakko P., Hirvikoski P., Kang S.W., Saily M., and Kinnula V.L. Peroxiredoxins, a novel protein family in lung cancer. Int. J. Cancer 111 (2004) 514-521
33. Li M., Zhai Q., Bharadwaj U., Wang H., Li F., Fisher W.E., Chen C., and Yao Q. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106 (2006) 2284-2294
34. Lieberman R. Chemoprevention of prostate cancer: current status and future directions. Cancer Metastasis Rev. 21 (2005) 297-309
35. Manthey J.A., and Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J. Agric. Food Chem. 50 (2002) 5837-5843
36. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., and Van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 (2003) 561-565
37. Park S.H., Chung Y.M., Lee Y.S., Kim H.J., Kim J.S., Chae H.Z., and Yoo Y.D. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin. Cancer Res. 6 (2000) 4915-4920
38. Quan C., Cha E.J., Lee H.L., Han K.H., Lee K.M., and Kim W.J. Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J. Urol. 175 (2006) 1512-1516
39. Ramadass P., Meerarani P., Toborek M., Robertson L.W., and Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol. Sci. 76 (2003) 212-219
40. Rhee S.G. Cell signaling. H2O2, a necessary evil for cell signaling. Science 312 (2006) 1882-1883
41. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
42. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533 (2003) 37-65
43. Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., and Rice-Evans C. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322 (1995) 339-346
44. Saleem M., Adhami V.M., Siddiqui I.A., and Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr. Cancer 47 (2003) 13-23
45. Takagi T., Takekoshi S., Okabe T., Nagata H., Honma T., and Watanabe K. Quercetin, a flavonol, promotes disassembly of microtubules in prostate cancer cells: possible mechanism of its antitumor activity. Acta Histoxhem. Cytochem. 31 (1998) 435-445
46. Tamura M., Nishizaka S., Maeda Y., Ito M., Harashima N., Harada M., Shichijo S., and Itoh K. Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes. Jpn. J. Cancer Res. 92 (2001) 762-767
47. Thannickal V.J. The paradox of reactive oxygen species: injury, signaling, or both?. Am. J. Physiol.: Lung Cell Mol. Physiol. 284 (2003) L24-L25
48. Topanurak S., Sinchaikul S., Phutrakul S., Sookkheo B., and Chen S.T. Proteomics viewed on stress response of thermophilic bacterium Bacillus stearothermophilus TLS33. Proteomics 5 (2005) 3722-3730
49. Vijayababu M.R., Arunkumar A., Kanagaraj P., and Arunakaran J. Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J. Carcinog. 5 (2006) 10
50. Williams J.A., Martin F.L., Muir G.H., Hewer A., Grover P.L., and Phillips D.H. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21 (2000) 1683-1689
51. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653
52. Wood Z.A., Schroder E., Robin H.J., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
53. Yanagawa T., Iwasa S., Ishii T., Tabuchi K., Yusa H., Onizawa K., Omura K., Harada H., Suzuki H., and Yoshida H. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett. 156 (2000) 27-35
54. Zhang Y.M. Protective effect of quercetin on Aroclor 1254-induced oxidative damage in cultured chicken spermatogonial cells. Toxicol. Sci. 88 (2005) 545-550
55. Zhang P., Liu B., Kang S.W., Seo M.S., Rhee S.G., and Obeid L.M. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 272 (1997) 30615-30618